ABSTRACT
In the past, few HLA-DR proteins were found to be associated with autoimmune diseases, e.g. HLA-DRB1 * 0401 with rheumatoid arthritis. It is important for the treatment of autoimmune diseases to determine which peptides bind to MHC class II molecules (HLA-DR) that will help in treatment of these diseases. The experimental methods for identification of these peptides are both time-consuming and cost-intensive. Computational methods thus, provide a cost effective way to identify these peptides. However, it is difficult to predict the peptides binding with HLA-DR molecules as compared to MHC class I molecules due to (i) variable length of binding peptides, (ii) undetermined core for each binding peptides and (iii) range of amino acids occupying anchor position for each MHC allele .
Over the years, a number of methods have been developed for the prediction of HLA-DR4 binding peptides from an antigenic sequence, beginning with, early motif based methods (Chicz et al., 1993; Sette et al., 1993; Hammer et al., 1993 , * To whom correspondence should be addressed. Max et al., 1993; Rammensee et al., 1995) ; to different scoring matrices based methods (Marshal et al., 1995; Southwood et al., 1998; Sturniolo et al., 1999; Reche et al., 2002) . The artificial neural network has also been applied for the prediction of HLA-DRB1 * 0401 binding peptides Honeyman et al., 1998) . Recently, few complex tools for identifying the HLA-DRB1 * 0401 binding peptides have also been designed, i.e. an iterative algorithm to optimize MHC class II binding matrix based stepwise discriminant analysis (Mallios, 1999) . To improve the prediction accuracy, here we have developed a support vector machine (SVM) based method for predicting HLA-DRB1 * 0401 binding peptides.
HLA-DRB1 * 0401 binding peptides of nine or more than nine amino acids were obtained from MHCBN database (Bhasin et al., 2003) . The binding cores (nine amino acids) from these peptides were obtained by using matrix optimization techniques (MOTs) package without considering MHC binding motifs (Singh and Raghava, unpublished data). HLA-DRB1 * 0401 non-binders of nine or more than nine amino acids were also obtained from the same database. Nonbinders were chopped into overlapping peptides of nine amino acids. All the duplicate peptides and peptides with unnatural amino acids were removed from the binders and non-binders data set. The final data set consisted of 567 unique MHC binders and equal number of unique non-binders (randomly chosen from non-binders). The final ratio of MHC binders and non-binders was kept 1 : 1 so that the performance of the method can be evaluated by considering the single parameter accuracy at a cutoff score where sensitivity and specificity are nearly same.
SVM based method was developed using package SVM_ LIGHT. (Joachims, 1999; Cristianini and Shawe-Taylor, 2000) . In this study, we represented amino acids by 20 dimension vector, so input was a vector of dimension 9 × 20 = 180 for binders/non-binders of length nine. Performance of SVM is kernel-dependent, so we tried all types of kernels i.e. RBF, Polynomial, Sigmoid and LINEAR, and identified the kernel which gave best performance for our study. It was observed that RBF kernel is the best in classifying the data of a Sensitivity is the percent of correctly predicted binders; Specificity is the percent of correctly predicted non-binders; PPV is Positive Probability Value (the probability that a predicted binder will be a binder); NPV is Negative Probability Value (the probability that a predicted non-binder will be a non-binder); accuracy is the percent of correct predictions (both binders and non-binders). b In case of Reche et al. (2002) , the binding threshold 5 is used instead of 22, as suggested by the authors of this paper. The threshold 5 is used to bring the sensitivity and specificity of prediction nearly equal.
DRB1 * 0401 binders and non-binders. In this study, we used the cutoff value where sensitivity and specificity were nearly equal for evaluating and developing SVM based method. The regulatory parameters c and g of RBF kernel were optimized to 5 and 0.1, respectively. We also developed ANN based method using publicly available free simulation package SNNS4.2 (Zell and Mamier, 1997) in order to test performance of ANN based method on our data set. The training was carried out by using the standard feed-forward back propagation network with single hidden layer. The ultimate value of learning rate, learning cycles and hidden nodes were determined by monitoring the error on the training set. The values of hidden nodes, learning rate and cycles were optimized to 1, 0.01 and 300, respectively. Both SVM and ANN were provided with binary inputs (supplementary material).
In this study, 5-fold cross-validation was used to develop and assess the performance of both SVM and ANN based methods. The data set was randomly divided into the five sets, each consisting of equal number of binders and non-binders. The methods were trained on four sets and tested on remaining single set; this process was repeated five times so that each set was used as test set once. The SVM based method achieved an accuracy of ∼86% at a cutoff score where the sensitivity (∼85%) and specificity (∼87%) were nearly equal. The accuracy of the ANN based method developed in the present study is 78%. We also tested the performance of previously published methods on our data set. The performance of existing algorithms and our methods is shown in Table 1 . One of the reasons of poor performance of existing methods is that these methods were designed from limited amount of data and in most of the cases non-binders were not used. Another inference obtained from the results is that SVM is superior to ANN in classifying data of MHC binders and non-binders.
In order to evaluate performance of our methods rigorously, we evaluated them on the data sets used in previous studies. All the binders used by previous methods were obtained from the literature and predicted by our methods on default threshold. As shown in Table S1 (supplementary material), our methods correctly predict all binders as binders for number of data sets. This demonstrates that our methods are not only suitable for data sets used in this study but also perform equally well on previously used data sets.
All the methods reported in literature as well as our methods were further evaluated on a blind data set created by Singh and Raghava (unpublished data; http://www.imtech.res.in/ raghava/mhcbench/). This blind data set consisted 1017 peptides [694 binders and 323 non-binders, all unique peptides (duplicate peptides) and peptides having no-natural amino acids were removed from data set] of length nine that have been experimentally verified as binders or non-binders to HLA-DRB1 * 0401. These peptides were obtained from MHCPEP, MHCBN and the published literature (see Supplementary material) . The performance of all methods on this data set is shown in the Table S2 (Supplementary material). The table illustrates that SVM based method developed in this study, outperformed all previously developed methods. The accuracy of ANN based method developed in this is study drastically drops to 42%.
The cross-validation by dividing data set into training and testing subset is the most common way to evaluate the performance of method. Infact, this is not true blind test for newly developed methods because same data is ultimately used to develop the methods. As shown in Tables S1 and S2, the performance of ANN dropped drastically when evaluated on blind/independent data set (data set not used either for testing or training). This indicates that commonly used crossvalidation technique is not true validation. The developers should evaluate the performance of their method on data set, which is neither used, for training nor for testing. It was also observed that the performance of linear methods (statistical methods) is as good as non-linear methods (e.g. ANN). The SVM based method developed in this study performs well on all data sets.
A web server HLADR4Pred has been developed for predicting HLA-DRB1 * 0401 binding peptide. The server allows user to feed sequence in any standard sequence format (e.g. PIR, FASTA, EMBL). The server provides options of varying cutoff score to vary the stringency of prediction. These observations, on DRB1 * 0401 is universal so, it can be extended to other alleles for which the sufficient amount of data is available. In conclusion, these methods would find application in cellular immunology, transplantation, vaccine design, immunodiagnostics, immunotherapeutics and molecular understanding of autoimmune susceptibility.
